Delivery Order SPE2DB24D9155-SPE2DB24FHZFF
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $18,526.83 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract, which runs through December 31, 2025, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB indefinite delivery contract valued up to $499,999,999. The contract is for the delivery of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $11,849.81 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items, including both common and...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. The order, valued at $7,400.64, is for the supply of a wide range of pharmaceutical products, including both branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products are to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
- SPE2DB24D9155Indefinite Delivery Contract
- SPE2DB24D9155-SPE2DB24FHZFFDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The awarded delivery order, valued at $18,526.83, covers the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the diverse medical requirements of the Department of Defense's healthcare facilities. This contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/7/24 |